AlgoNomics Overview

  • Founded
  • 1999
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

AlgoNomics General Information

Description

Provider of structural bioinformatics services. The company provides structural bioinformatics tools to develop rationally designed therapeutics in the broad field of immunotherapy.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Acquirer
Primary Office
  • Technologiepark 4
  • 9052 Ghent
  • Belgium
+32 09 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AlgoNomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 02-Nov-2009 00.000 Completed Generating Revenue
4. Later Stage VC 27-Jun-2007 00.000 00.000 Completed Generating Revenue
3. Grant 21-Feb-2002 00000 00.000 Completed Startup
2. Early Stage VC 06-Jun-2001 $1.56M $1.56M Completed Startup
1. Early Stage VC Completed
To view AlgoNomics’s complete valuation and funding history, request access »

AlgoNomics Executive Team (2)

Name Title Board Seat Contact Info
Ignace Lasters Chief Scientific Officer
You’re viewing 1 of 2 executive team members. Get the full list »

AlgoNomics Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BNP Paribas Fortis Private Equity Growth/Expansion Minority 000 0000 000000 0
Baekeland Fonds II Corporation Minority 000 0000 000000 0
Investco Real Estate Minority 000 0000 000000 0
KBC Private Equity PE/Buyout Minority 000 0000 000000 0
KU Leuven Research & Development Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »